secondary ALCL

GPTKB entity

Statements (59)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:associated_with gptkb:HIV
autoimmune diseases
gptkbp:can_metastasize_to initial treatment
gptkbp:displacement other lymphomas
gptkbp:has_achievements secondary infections
organ dysfunction
https://www.w3.org/2000/01/rdf-schema#label secondary ALCL
gptkbp:is_associated_with chronic inflammation
EBV infection
poor prognosis in some cases
previous malignancies
gptkbp:is_characterized_by C D30 positivity
large atypical lymphoid cells
ALK negativity
expression of T-cell markers
pleomorphic morphology
gptkbp:is_considered a rare disease
a subtype of T-cell lymphoma
a type of non-Hodgkin lymphoma
gptkbp:is_described_as gptkb:academic_journal
gptkbp:is_discussed_in oncology conferences
gptkbp:is_documented_in gptkb:municipality
gptkbp:is_evaluated_by oncologists
pathologists
hematologists
gptkbp:is_monitored_by regular follow-up examinations
gptkbp:is_noted_for its aggressive nature
potential for transformation
gptkbp:is_often_used_in gptkb:primary_ALCL
immunocompromised patients
gptkbp:is_part_of hematologic malignancies
the WHO classification of lymphomas
the spectrum of T-cell lymphomas
gptkbp:is_recognized_by specific genetic alterations
gptkbp:is_related_to gptkb:primary_ALCL
gptkbp:is_studied_in clinical trials
gptkbp:is_subject_to research studies
gptkbp:is_used_for weight loss
fever
night sweats
lymphadenopathy
gptkbp:occurs_in gptkb:Person
adults
chemotherapy for other cancers
radiation therapy for other cancers
gptkbp:reports_to case studies
gptkbp:requires multidisciplinary management
intensive treatment
gptkbp:scientific_classification a peripheral T-cell lymphoma
gptkbp:social_responsibility biopsy
flow cytometry
immunohistochemistry
variable outcomes
gptkbp:treatment radiation therapy
chemotherapy
stem cell transplant
gptkbp:bfsParent gptkb:anaplastic_large_cell_lymphoma,_ALK-positive
gptkbp:bfsLayer 6